Terumo Neuro Signs Agreement to Acquire Arsenal Medical - Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH)

As reported by manilatimes.net

Proposed acquisition would add NeoCast™, an investigational technology designed for controlled delivery and predictable distal penetration, to Terumo Neuro’...

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on manilatimes.net ↗

Market Samachar is a news aggregator. This article was originally published by manilatimes.net. Tap the button above to read the full story on their site.

INDIAN Sensex, Nifty impact Explained: Why 30-year US Treasury bond yields surged to 2002 levels and why it matters to India? mint - markets
INDIAN Inox Clean Energy plans ₹10,000 crore IPO, files papers with Sebi Share Market Today
INDIAN Stock Market LIVE: Sensex gains 300 pts, Nifty around 22,750; India VIX falls 5% Share Market Today
GLOBAL Africa's richest man to launch Kenya oil refinery despite land protests BBC News
INDIAN Anthropic IPO explained: $2 trillion valuation, ballooning net loss, AI risks and other details in leaked IPO papers Markets-Economic Times
COMPANIES Re-rating on cars for HAL shares as Tejas Mk1A aircraft deliveries near: Jefferies Stocks-Markets-Economic Times
INDIAN Global Market: European shares head for first monthly decline in six months as yields rise Markets-Economic Times
INDIAN Global Market: Euro under pressure from energy shock and political risks Markets-Economic Times

Terumo Neuro Signs Agreement to Acquire Arsenal Medical - Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH)

More from Market Samachar